NCT00644982 - A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression | Biotech Hunter

Enrollment

163

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

September 30, 2003

Conditions

Depressive Disorder, Major

Interventions

DRUG

sertraline

Flexibly-titrated 50 mg tablets, 50-150 mg/day and venlafaxine placebo orally for 10 weeks.

DRUG

venlafaxine XR

Flexibly-titrated 75 mg capsules, 75-225mg/day and sertraline placebo orally for 10 weeks.

Trial Locations (14)

Pfizer Investigational Site, WEST Heidelberg

Pfizer Investigational Site, Heidelberg

Pfizer Investigational Site, Box Hill

Pfizer Investigational Site, Everton Park

Pfizer Investigational Site, Cairns

Pfizer Investigational Site, North Cairns

Pfizer Investigational Site, West Perth

Pfizer Investigational Site, Adana

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Diyarbakır

Pfizer Investigational Site, Istanbul

Pfizer Investigational Site, Izmir

Pfizer Investigational Site, İzmit

Pfizer Investigational Site, Malatya

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY